The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).

Clinical trial NCT01556477 · UNKNOWN

Trial details

NCT number: NCT01556477
Sponsor: Nordic MDS Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Acute Myelogenous Leukemia

Start date: 2012-03-01
Primary completion: 2014-07-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.